Tobacco PreventionNCT02725021
Education Against Tobacco Randomized Trial in Brazil
A study testing Education Against Tobacco school-based intervention by medical students in people with Tobacco Prevention, run by University of Giessen.
Trial summary
A two armed randomized trial is evaluating the effect of the medical-student-delivered school-based intervention Education Against Tobacco on the smoking behavior of adolescents in 7-11th grade of secondary school. The primary endpoint is the change in smoking prevalence between the two groups. Read more about this study
- Who is it for?
- Ages 5 to 25 yearsHealthy volunteers can take part
- Conditions the study is for
- Tobacco Prevention
- What is being tested?
- Education Against Tobacco school-based intervention by medical students
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 1,500 participants
- Where
- No sites listed yet
- Study dates
- Oct 2016to Apr 2018
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 5 to 25 years
- All sexes
- Healthy volunteers accepted
- Child, Adult
Who may be able to join
- Visiting grades 7-11 of a regular public secondary school in Brazil.
Who cannot join
- Not fulfilling inclusion criteria.
About this study
Official title: Education Against Tobacco: Medical-student-delivered Smoking Prevention Programme for Secondary Schools in Brazil - Randomized Trial
A two armed randomized trial is evaluating the effect of the medical-student-delivered school-based intervention Education Against Tobacco on the smoking behavior of adolescents in 7-11th grade of secondary school. The primary endpoint is the change in smoking prevalence between the two groups.
- Conditions
- Tobacco Prevention
- Being tested
- Education Against Tobacco school-based intervention by medical students
- Keywords
- tobacco prevention
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Education Against Tobacco school-based intervention by medical studentsBehavioural
| Study group | Role | What they receive |
|---|---|---|
| Intervention group | Experimental | The intervention group receives a school-based module taking about two hours delivered by medical students in the schools. Receives: Behavioral: Education Against Tobacco school-based intervention by medical students |
| Control group | No intervention | Not described |
What is being measured
The primary outcome is the main question the study is designed to answer.
Smoking prevalence measured via questionnaire.
Measured: 12 months follow-up
Secondary outcomes (3)
Smoking onset: Difference in the number of new smokers at 12 months of follow-up who were not present at baseline
Measured: Baseline and 12 months
Difference in the number of new non-smokers at 12 months of follow-up who were smoking at baseline
Measured: Baseline and 12 months
Relevant differences due to the theory of planned behaviour between the two groups measured via questionnaire.
Measured: Difference in attitude towards smoking between the two groups at 12 months follow-up measured via questionnaires.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted31 Mar 2016 (estimated)
- Study startOct 2016
- Primary completionFeb 2018 (estimated)
- Study completionApr 2018 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for Tobacco PreventionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 1,500 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Giessen
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Titus J. Brinker, University of Giessen
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02725021
- Sponsor's protocol ID
- EATBrazil
- Status last verified
- Apr 2016
- First submitted
- 13 Mar 2016
- Last updated
- 5 Jun 2017
- Results posted
- No
- Data monitoring committee
- No
- Individual data sharing
- Undecided
Publications
Lisboa OC, Bernardes-Souza B, Xavier LEF, Almeida MR, Correa PCRP, Brinker TJ. A Smoking Prevention Program Delivered by Medical Students to Secondary Schools in Brazil Called "Education Against Tobacco": Randomized Controlled Trial. J Med Internet Res. 2019 Feb 21;21(2):e12854. doi: 10.2196/12854.
PubMed 30789347Xavier LE, Bernardes-Souza B, Lisboa OC, Seeger W, Groneberg DA, Tran TA, Fries FN, Correa PC, Brinker TJ. A Medical Student-Delivered Smoking Prevention Program, Education Against Tobacco, for Secondary Schools in Brazil: Study Protocol for a Randomized Trial. JMIR Res Protoc. 2017 Jan 30;6(1):e16. doi: 10.2196/resprot.7134.
PubMed 28137703
Study at a glance
From the registry record, last updated by the sponsor on 5 Jun 2017. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Education Against Tobacco: Medical-student-delivered Smoking Prevention Programme for Secondary Schools in Brazil - Randomized Trial
- ClinicalTrials.gov ID
- NCT02725021
- Acronym / sponsor ID
- EATBrazil
- Conditions
- Tobacco Prevention
- Keywords
- tobacco prevention
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 1,500 participants (estimated)
- Lead sponsor
- University of GiessenUniversity, hospital or other
- Study start
- Oct 2016
- Primary completion
- Feb 2018 (estimated)
- Study completion
- Apr 2018 (estimated)
- First posted
- 31 Mar 2016 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
A two armed randomized trial is evaluating the effect of the medical-student-delivered school-based intervention Education Against Tobacco on the smoking behavior of adolescents in 7-11th grade of secondary school. The primary endpoint is the change in smoking prevalence between the two groups.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Intervention group | Experimental | Behavioral: Education Against Tobacco school-based intervention by medical studentsThe intervention group receives a school-based module taking about two hours delivered by medical students in the schools. |
| Control group | No intervention | – |
Who may qualify
- Ages
- 5 to 25 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult
Key inclusion criteria (1 listed)
- Visiting grades 7-11 of a regular public secondary school in Brazil.
Key exclusion criteria (1 listed)
- Not fulfilling inclusion criteria.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Education Against Tobacco school-based intervention by medical students | Behavioural | Intervention group |
Primary outcome
Smoking prevalence measured via questionnaire.
Time frame: 12 months follow-up
3 secondary outcomes
Smoking onset: Difference in the number of new smokers at 12 months of follow-up who were not present at baseline
Time frame: Baseline and 12 months
Difference in the number of new non-smokers at 12 months of follow-up who were smoking at baseline
Time frame: Baseline and 12 months
Relevant differences due to the theory of planned behaviour between the two groups measured via questionnaire.
Time frame: Difference in attitude towards smoking between the two groups at 12 months follow-up measured via questionnaires.
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 5 Jun 2017.
- Derived from this study: PubMed 30789347Lisboa OC, Bernardes-Souza B, Xavier LEF, Almeida MR, Correa PCRP, Brinker TJ. A Smoking Prevention Program Delivered by Medical Students to Secondary Schools in Brazil Called "Education Against Tobacco": Randomized Controlled Trial. J Med Internet Res. 2019 Feb 21;21(2):e12854. doi: 10.2196/12854.
- Derived from this study: PubMed 28137703Xavier LE, Bernardes-Souza B, Lisboa OC, Seeger W, Groneberg DA, Tran TA, Fries FN, Correa PC, Brinker TJ. A Medical Student-Delivered Smoking Prevention Program, Education Against Tobacco, for Secondary Schools in Brazil: Study Protocol for a Randomized Trial. JMIR Res Protoc. 2017 Jan 30;6(1):e16. doi: 10.2196/resprot.7134.
- Individual participant dataSharing planned: Undecided
Related trials for Tobacco Prevention
Not yet recruiting
QAIAx - SGI/SI Smart Health Cities: Microcity Enclave Program (Quantum SI/AGI Agency a/k/a AI City Hall Project - UPSTO App Nos. 64/074,526, 64/063,557, 64/105,164, 63/903,181, 63/729,428, 64/125,360; USPTO EO 9424 Assignment ID: 2101042 / ARN: REEL/FRAME: 76481/0026 - OUSD-R&E, Department of War)
Asperger's Disorder, Asperger Disorder
Not yet recruiting
Impact of Lung Cancer Screening With Chest Scans Combined With Coaching on Smoking Cessation in Heavy Smokers
Lung Cancer (Diagnosis), Smoking Cessation
Recruiting
Smoking Relapse Prevention in Patients With Cancer
Cancer, Tobacco Use
Not yet recruitingPhase 4
The INTERvening for LUNG Health Trial
Spirometry
Active, not recruiting
Evaluation of Effectiveness of the LifeSkills Training - Lombardia - Primary Shool Program ( Val3P-LST )
Well Being, Drug Addiction
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
A study testing Education Against Tobacco school-based intervention by medical students in people with Tobacco Prevention, run by University of Giessen.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 5 Jun 2017. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Smoking prevalence measured via questionnaire. (time frame: 12 months follow-up). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT02725021, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Jun 2017.